Jin Sook Chung
Ufficiale delle Risorse Umane presso IOMAI CORPORATION
Provenienza dei contatti di primo grado di Jin Sook Chung
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Biotechnology | 19 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jin Sook Chung tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| NOVAVAX, INC. | Biotechnology | Chairman Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| MAXCYTE, INC. | Biotechnology | Director/Board Member Chairman | |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Pharmaceuticals: Major | Director/Board Member Founder | |
| ALDEYRA THERAPEUTICS, INC. | Biotechnology | Chairman | |
| Dartmouth College | College/University | Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
| University of Illinois | College/University | Undergraduate Degree Doctorate Degree | |
| University of Michigan | College/University | Undergraduate Degree | |
| Washington State University | College/University | Doctorate Degree | |
| The Pew Charitable Trusts | Investment Trusts/Mutual Funds | Human Resources Officer | |
| American Social Health Association | Director/Board Member | ||
The National Center for Genome Resources
 The National Center for Genome Resources Miscellaneous Commercial ServicesCommercial Services The National Center for Genome Resources operates as a non-profit research institute for applied software engineering and next-generation sequencing to solve the preeminent challenges of 21st century biology through collaborative research and services. Its capabilities include genome, transcriptome, methylome, ChIP, small RNA, and exome sequencing, with corresponding analytical capabilities. The company is headquartered in Santa Fe, NM. | Miscellaneous Commercial Services | Director/Board Member | |
The National Center for Healthy Housing
 The National Center for Healthy Housing Miscellaneous Commercial ServicesCommercial Services The National Center for Healthy Housing is a non-profit organization which engages in the sucuritization of homes. Its programs include demystifying healthcare financing, equipping states for reimbursement, housing checkup, New York State CLPPP Program, and healthy housing challenge. The company was founded in 1992 and is headquartered in Columbia, MD. | Miscellaneous Commercial Services | Chairman | |
Integrated Genetics, Inc.
 Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Part of Laboratory Corp. of America Holdings, Integrated Genetics, Inc. is a pharmaceutical preparations company. The company is based in Framingham, MA. The company was founded by Robert J. Carpenter. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The Colorado Department of Public Health & Environment | General Government | Director/Board Member | |
Association of State & Territorial Health Officials
 Association of State & Territorial Health Officials Miscellaneous Commercial ServicesCommercial Services The Association of State & Territorial Health Officials (ASTHO) is a national non-profit organization that represents public health agencies in the United States, including the territories and freely associated states, as well as the District of Columbia. The organization is based in Arlington, VA. ASTHO's members are the chief health officials of these jurisdictions, who are committed to developing and influencing effective public health policies and ensuring high-quality public health practices. | Miscellaneous Commercial Services | President | |
Partnership for Prevention
 Partnership for Prevention Miscellaneous Commercial ServicesCommercial Services Partnership for Prevention provides disease prevention and health promotion services. The company was founded in 1991 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
Valneva Scotland Ltd.
 Valneva Scotland Ltd. BiotechnologyHealth Technology Part of Valneva SE, Valneva Scotland Ltd. is a British vaccine company that specializes in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Livingston, UK. The company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and chikungunya. Valneva's portfolio also includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| SENSORION | Pharmaceuticals: Major | Director of Finance/CFO | |
| VALNEVA | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Chief Executive Officer Director of Finance/CFO | |
| Johns Hopkins Bloomberg School of Public Health | College/University | Corporate Officer/Principal Graduate Degree | |
| Grimaud Deyang Animal Co. Ltd. | Director/Board Member | ||
Valneva Austria GmbH
 Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Valneva SE, VALNEVA Austria GmbH is an Austrian biotechnology company that develops and commercializes vaccines for infectious diseases. The company is based in Vienna, Austria. The CEOs are Thomas Lingelbach, Franck Charles Marie Grimaud, Frédéric Jacotot. The company was founded in 2013. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Chief Executive Officer Corporate Officer/Principal | |
| Elatos GmbH | Chief Executive Officer Corporate Officer/Principal | ||
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal | |
QSpine Ltd.
 QSpine Ltd. Medical SpecialtiesHealth Technology QSpine Ltd. designs, manufactures and distributes medical devices in the surgical spine market segment. Its products include Mobi-C, sterispine pedicle screw, sterispine lumber cage and spinetune and shivas cervical cage. The company was founded by Forbes Butterfield and Stuart Hunter Carmichael in 2011 and is headquartered in Corby, the United Kingdom. | Medical Specialties | Director/Board Member | |
Vaccines Holdings Sweden AB
 Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014. | Biotechnology | Director/Board Member Chief Executive Officer Chairman Director/Board Member | |
Helio Vision, Inc.
 Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
Valneva Sweden AB
 Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
EnteroBiotix Ltd.
 EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom. | Medical Specialties | Director/Board Member | |
| Intercell Austria AG | Corporate Officer/Principal Chief Executive Officer | ||
Valneva UK Ltd.
 Valneva UK Ltd. Medical/Nursing ServicesHealth Services Part of Valneva SE, Valneva UK Ltd. provides health care services. The company is based in London, UK and was founded in 2015. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Valneva Canada, Inc.
 Valneva Canada, Inc. Medical DistributorsDistribution Services Part of Valneva SE, Valneva Canada, Inc. engages in marketing and distribution of vaccines. The company is based in Kirkland, Canada. | Medical Distributors | Director/Board Member President Director/Board Member | |
| Stuart & Muir Consulting Ltd. | Director/Board Member | ||
| Agprome Ltd. | Director/Board Member | ||
Synpromics Agbiosub Ltd.
 Synpromics Agbiosub Ltd. Miscellaneous Commercial ServicesCommercial Services Synpromics Agbiosub Ltd. is a British company that engages in research and experimental development on biotechnology. The private company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member | |
| Valneva USA, Inc. | Director/Board Member Chief Executive Officer Chief Executive Officer | ||
ACM Biolabs Pte Ltd.
 ACM Biolabs Pte Ltd. BiotechnologyHealth Technology ACM Biolabs Pte Ltd. operates as a synthetic biology company which uses its ACM technology platform to allow clients to develop diagnostics, therapeutics and vaccines targeting novel membrane proteins. The company was founded by Madhavan Nallani in 2013 and is headquartered in Singapore. | Biotechnology | Director/Board Member | |
| Labyrinth Choir, Inc. | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 33 |
| Regno Unito | 8 |
| Austria | 5 |
| Francia | 3 |
| Svezia | 3 |
Settori
| Health Technology | 23 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Electronic Technology | 2 |
| Miscellaneous | 2 |
Posizioni
| Director/Board Member | 86 |
| Corporate Officer/Principal | 52 |
| Chief Executive Officer | 22 |
| Chairman | 20 |
| President | 16 |
Contatti più connessi
| Insiders | |
|---|---|
| David Lawrence | 29 |
| Jeff Himawan | 24 |
| Franck Grimaud | 22 |
| R. Gordon Douglas | 21 |
| Thomas Lingelbach | 17 |
| James Young | 15 |
| Richard Kenney | 14 |
| Thomas Martin Vernon | 13 |
| Stanley Erck | 10 |
| Reinhard Kandera | 10 |
| Richard Douglas | 10 |
| Gregory Glenn | 7 |
| F. Weller Meyer | 6 |
| Russell Wilson | 6 |
| Sarah A. Frech | 5 |
- Borsa valori
- Insiders
- Jin Sook Chung
- Connessioni Società
